tradingkey.logo

Livanova Announces Core-Vns 24-Month Data Show Adjunctive Vns Therapy Is Associated With Substantial Reductions In Generalized Tonic-Clonic Seizures In People With Drug-Resistant Epilepsy

ReutersJun 5, 2025 12:04 PM

- LivaNova PLC LIVN.O:

  • LIVANOVA ANNOUNCES CORE-VNS 24-MONTH DATA SHOW ADJUNCTIVE VNS THERAPY IS ASSOCIATED WITH SUBSTANTIAL REDUCTIONS IN GENERALIZED TONIC-CLONIC SEIZURES IN PEOPLE WITH DRUG-RESISTANT EPILEPSY

  • LIVANOVA PLC - 77% MEDIAN SEIZURE REDUCTION, 43% SEIZURE FREEDOM AT 24 MONTHS

  • LIVANOVA PLC - 52% MEDIAN SEIZURE REDUCTION AT THREE MONTHS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI